Investors Snag VRCA Even Lower Than Its Secondary Stock Offering
March 24, 2021 at 11:03 AM EDT
Looking back to 2 days ago, Verrica Pharmaceuticals Inc (VRCA) priced a 2,033,899 share secondary stock offering at $14.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..